«
Human gene targeting by viral vectors.»
Not exact matches
'' «At PMV Pharmaceuticals, we are
targeting the most frequently mutated
gene in
human cancer (p53) to make an unprecedented impact on cancer patients» lives.
If Rudenko confirms Clark's PCR tests using additional
gene targets, and if Clark or Rudenko manage to grow Borrelia cultures out of
human and lone star tick samples, then even the fiercest skeptics will have to recognize that Southern Lyme strains threaten
human health, and that Lyme - like illness deserves Lyme - like treatment.
Our data demonstrate the feasibility of
targeted gene disruption in multiple rat strains within 4 months time, paving the way to a humanized monoclonal antibody platform and additional
human disease models.
Carlo Croce, a cancer researcher at Ohio State University in Columbus, and his colleagues created a diagram of interacting miRNAs for normal body cells by connecting them according to which
genes they
target and the function of those
genes, in a way similar to analyses of
human social networks.
After moving to Berkeley, he arrived at a career crossroads in 1994, when Spyros Artavanis - Tsakonas, then at Yale, discovered and subsequently patented the
human relative of the fruit fly
gene notch, which plays a role in cell - to - cell interactions and could be an anti-cancer
target.
«If these
genes would have a role [in
humans], it would be very exciting to try to [make] medicines that
target some of these
genes,» Moreno says.
In one experiment with
human cells, a guide RNA should have led the Cas9 enzyme only to a
gene on chromosome 2 (yellow bar), but it also directed the enzyme to many off -
target sites (red) on several other chromosomes.
The vector then unloads its genetic material containing the therapeutic
human gene into the
target cell.
Before moving on to
human trials, they will need to study all instances of «off -
target» effects: Years before Crispr, the viruses employed to deliver DNA in
gene therapy trials occasionally damaged the whole system, causing cancer.
It turns out that each virus that's been studied and associated with cancer — such as hepatitis B with liver cancer or
human papilloma virus with cervical cancer — evolves characteristics that allow it to
target those
genes immediately upon infection.
Yet a virus made so weak that it can not get us sick often can not even last long enough to deliver the
gene to its
target, being destroyed by the
human immune system before it arrives.
This and other evidence, say study authors Svante Pbo of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, and his colleagues, «strongly suggest that this
gene has been the
target of selection during recent
human evolution.»
Although that marker, called IL21, had not previously been associated with autoimmune diseases, the
gene that produces it sits right in the stretch of DNA known to make these mice vulnerable to diabetes, suggesting that IL21 might make a drug
target, says Sarvetnick.Furthermore, by giving the animals a shot of dead bacteria — similar to an immunization in
humans — when they were newborns, Sarvetnick and her colleagues prevented a surfeit of CD4 + and CD8 + cells.
In
humans, variants of the IL - 15R - alpha
gene have been found in world - class endurance competitors, suggesting a
target for
gene therapies aimed at boosting the ability to exercise longer.
Using in vitro, or test tube, experiments, the researchers applied these chemicals to
human cancer cells to measure changes of estrogen receptor - and androgen receptor -
target genes and transcriptional activity.
The researchers first used yeast to quickly and cheaply screen 169,000 interactions between yeast versions of
human tumor - suppressor
genes and
genes that can be inhibited with drugs, sometimes called «druggable»
targets.
In one experiment this year, a team led by another CRISPR pioneer, Feng Zhang of the Broad Institute in Cambridge, Massachusetts,
targeted the 20,000 or so known
human genes, turning them on one by one in groups of cells to identify those involved in resistance to a melanoma drug.
Researchers from KTH Royal Institute of Technology's Science for Life Laboratory (SciLifeLab) research center and Gothenburg University employed the biological networks generated for 46 major
human tissues in order to identify the liver - specific
gene targets.
Using a recently developed genome - editing technique called CRISPR, a Chinese team has successfully altered two
target genes in cynomolgus monkeys, paving the way for the development of monkey models that mimic
human diseases.
Ras is the most frequently mutated
human cancer
gene (oncogene), yet despite recent breakthroughs, therapeutic options to
target Ras - dependent cancers remain limited.
In 2013, CRISPR passed two important tests: It works in
human cells, and it can
target several
genes at once.
Previous research has shown that HIV - 1 integrates more frequently into
human genes that are transcribed into RNA (the first step in
gene expression), but the biological significance of this
targeting has been unclear.
Derived mostly from
human embryonic kidney 293T (HEK293T) and HeLa cell lines, EdiGene Knockout (KO) Cell Lysates have been optimized through the use of genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the
target gene.
In both
human airway cells and mouse nasal cells, the researchers observed corrections in the
targeted genes.
Earlier versions of these «base editors,» which
target typos related to the other half of disease - causing genetic spelling errors, have already been used to alter
genes in plants, fish, mice and even
human embryos.
In 2006 Pfizer started early
human testing on one of these new,
targeted drugs called crizotinib (now sold as Xalkori), concentrating on a mutation of a
gene called MET, implicated in several cancers, including esophageal and stomach cancer.
Most simply, once these
genes, or bits of DNA tied to the
genes (known as markers), have been identified, molecular breeders can quickly
target offspring inheriting the
genes for further development, cutting breeding time and improving the crop's «genetic gain,» the generational improvements made to a crop, like increased height, by
human selection.
Whereas in the nematode experiment the researchers
targeted nanoparticles to temperature - sensitive ion channels that naturally exist in the membranes of the worms» nerve cells, the scientists inserted the
gene for a heat - activated ion channel called TRPV1 into the
human and rat cells.
He says HGS was getting «diminishing returns» from its investment in TIGR since Venter had steered his outfit into sequencing organisms of little medical importance, and into
human genome sequencing, also of limited value for a company like HGS that is interested in
genes as drug
targets (not untranslated DNA that makes up most of the genome).
The next step was to find out which role Shp2 and its
target genes play in
human patients with breast cancer.
One ZFN pair was used to
target both the
human and rhesus macaque CXCR4
genes since the 24 bp
target sequences are identical.
The team designed the PshRNA agent selectively
targeting the common sequence of
human and mouse (pro) renin receptor
genes.
Asuri, Prashanth, et al. «Directed evolution of adeno - associated virus for enhanced
gene delivery and
gene targeting in
human pluripotent stem cells.»
For
gene editing to work, it is essential to uniquely
target a single site among the 3 billion nucleotides in the haploid (single set of unpaired chromosomes)
human genome.
The first successful
targeted human gene therapy was reported in 2000.
Caribou's market - leading CRISPR - Cas9
gene editing technology can accurately
target and cut DNA to produce precise and controllable changes to the genome, which can be applied by JAX to create mouse models that better recapitulate
human diseases enabling researchers to find better treatments faster.
This was achieved after correction of the
human sickle hemoglobin allele by
gene - specific
targeting.
Thus, neural derivatives of disease - specific
human pluripotent stem cells constitute a relevant biological resource for exploring the impact of adult - onset HD mutations of the HTT
gene on the division of neural progenitors, with potential applications in HD drug discovery
targeting HTT - dynein - p150Glued complex interactions.
Although CRISPR is incredibly useful for generating mutations by NHEJ and generating small mutations with HDR, when it comes to larger scale genome editing, such as replacement of a mouse
gene with its
human ortholog (greater than 5 kb), it remains to be seen whether CRISPR is as robust as conventional
gene targeting.
This is a great example of a potential
gene therapy
target that still needs a fair amount of work to validate the thesis and the initial data, but having a large number of existing
human carriers is a good sign on the safety front.
Being able to go back and forth between the mouse and
human genomes so easily has also made it much simpler and quicker to
target related
human genes that could be candidates for drug development.
NGF is in fact viewed as a viable
target for AD clinical trials with one group investigating NGF ex vivo
gene delivery in a Phase 1 trial with
human patients aimed at stimulating cholinergic function and improving memory [123].
The sequences of small interfering RNA (siRNA)
targeting the
human mTOR, AKT1, and 4E - BP1
gene products were purchased from Ambion, Inc. (Austin, TX) and were as follows: mTOR sense GGAGUCUACUCGCUUCUAUTT and antisense AUAGAAGCGAGUAGACUCCTC, AKT1 sense GGGCACUUUCGGCAAGGUGTT and antisense CACCUUGCCGAAAGUGCCCTT, and 4E - BP1 sense GGUACCAGGAUCAUCUAUGTT and antisense CAUAGAUGAUCCUGGUACCTC.
We focus on developing computational methods and tools for (a) analyzing large - scale
gene expression data related to
human cancer in search for
gene markers and disease sub-categories, (b) identifying regulatory elements such as miRNA precursors and their
targets in whole genomes of plants and mammals, (c) building theoretical models of
gene regulatory networks.
And CRISPR has completely and utterly transformed the field, as we can do rapid
gene targeting now in primary
human neural stem cells.»
We conclude that the large number of mouse mutants and
human de novo mutations may be due to the combination of the Chd7
gene being a large
target and the fact that many heterozygous carriers of the mutations are viable individuals with a readily detectable phenotype.
In MMEJ pathway, we achieve efficient
gene disruption in
human cell lines and animals by developing a computer program that assists the choice of nuclease
target sites based on microhomology prediction.
Following a Forward Genetics approach, Fleming researchers identified a novel neurological mouse model caused by a functional mutation in the Slc25a46
gene, a new pathogenic
target in a wide spectrum of
human neurological diseases, including optic atrophy, Charcot - Marie - Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.
Targeted Gene Addition to a Safe Harbor locus in
human CD34 + Hematopoietic Stem Cells for Correction of X-linked Chronic Granulomatous Disease.